(Q42972501)

12 November 2017

1 reference

title

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity (English)

1 reference

12 November 2017

1 reference

2

1 reference

12 November 2017

Matthias G von Herrath

series ordinal

1

object named as

Matthias G von Herrath

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Journal of Experimental Medicine

12 November 2017

1 reference

12 November 2017

202

1 reference

12 November 2017

9

1 reference

12 November 2017

1159-1162

1 reference

Design of effective immunotherapy for human autoimmunity

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

The NOD mouse: a model of immune dysregulation

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Humanized animal models for autoimmune diseases

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Of mice and not men: differences between mouse and human immunology

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Effects of insulin in relatives of patients with type 1 diabetes mellitus

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213225

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

16 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.20051224

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16275758

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Active suppression of diabetes after oral administration of insulin is determined by antigen dosage

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16275758

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1084/JEM.20051224

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

16275758

1 reference